9.1 Hemorrhagic Shock Resuscitation & Massive Transfusion Protocols (MTP)
Key Takeaways
- Hemorrhagic shock resuscitation centers on Damage Control Resuscitation (DCR), avoiding crystalloid overload while enforcing permissive hypotension (target SBP 80–90 mmHg, MAP ~50–60 mmHg) until surgical source control is achieved—EXCEPT in traumatic brain injury (TBI), where target SBP must be ≥ 110 mmHg to maintain adequate cerebral perfusion pressure.
- The traditional Lethal Triad of Trauma (Hypothermia, Acidosis, and Coagulopathy) has expanded into the Lethal Diamond with the inclusion of Hypocalcemia (ionized calcium < 0.9–1.1 mmol/L), driven by citrate toxicity from rapid blood product transfusion.
- Massive Transfusion Protocol (MTP) utilizes a balanced 1:1:1 blood product ratio (PRBCs : FFP : Platelets) or Low-Titer O Positive/Negative Whole Blood (LTOWB) to restore oxygen-carrying capacity and maintain coagulation factor parity.
- Tranexamic Acid (TXA) must be administered as a 1 g IV/IO bolus over 10 minutes within 3 hours of trauma, followed by a 1 g IV infusion over 8 hours, to competitively inhibit hyperfibrinolysis.
- Viscoelastic testing (TEG/ROTEM) guides targeted component therapy: prolonged R-time dictates FFP/PCC; low Alpha angle/K-time dictates Cryoprecipitate; decreased MA dictates Platelets/DDAVP; elevated LY30 dictates TXA.
9.1 Hemorrhagic Shock Resuscitation & Massive Transfusion Protocols (MTP)
Hemorrhagic shock remains the leading cause of preventable death in trauma patients. Modern critical care transport requires a fundamental paradigm shift away from high-volume crystalloid resuscitation toward Damage Control Resuscitation (DCR), balanced blood product administration, and target-driven hemostatic optimization.
Pathophysiology & Classification of Hemorrhagic Shock
Hemorrhagic shock is a hypovolemic state resulting from rapid intravascular volume depletion, causing tissue hypoperfusion, cellular hypoxia, systemic anaerobic metabolism, and progressive lactic acidosis. The American College of Surgeons Advanced Trauma Life Support (ATLS) categorizes hemorrhage into four distinct physiological classes:
| Parameter | Class I (Mild) | Class II (Moderate) | Class III (Severe) | Class IV (Life-Threatening) |
|---|---|---|---|---|
| Blood Loss (mL) | $< 750 \text{ mL}$ | $750 - 1500 \text{ mL}$ | $1500 - 2000 \text{ mL}$ | $> 2000 \text{ mL}$ |
| Blood Loss (% Volume) | $< 15%$ | $15% - 30%$ | $30% - 40%$ | $> 40%$ |
| Heart Rate (bpm) | $< 100$ | $100 - 120$ | $120 - 140$ | $> 140$ |
| Systolic Blood Pressure | Normal | Normal | Decreased ($< 90 \text{ mmHg}$) | Severely Decreased |
| Pulse Pressure | Normal / Increased | Narrowed | Narrowed | Severely Narrowed |
| Respiratory Rate | $14 - 20$ | $20 - 30$ | $30 - 40$ | $> 35$ |
| Urine Output (mL/hr) | $> 30 \text{ mL/hr}$ | $20 - 30 \text{ mL/hr}$ | $5 - 15 \text{ mL/hr}$ | Negligible |
| Mental Status / GCS | Slightly Anxious | Mildly Anxious | Anxious / Confused | Confused / Lethargic |
| Base Deficit | $0 \text{ to } -2 \text{ mEq/L}$ | $-2 \text{ to } -6 \text{ mEq/L}$ | $-6 \text{ to } -10 \text{ mEq/L}$ | $< -10 \text{ mEq/L}$ |
The Lethal Triad to the Lethal Diamond of Trauma
Traumatic injury triggers a vicious self-amplifying pathological spiral traditionally known as the Lethal Triad of Trauma, which consists of:
- Hypothermia ($< 35^\circ\text{C}$): Impairs the enzymatic function of the coagulation cascade. At core temperatures $< 33^\circ\text{C}$, clotting factor synthesis and platelet aggregation drop by over 50%.
- Acidosis ($\text{pH} < 7.20$): Lactic acidosis directly inhibits coagulation factor assembly. The activity of the Factor VIIa/Tissue Factor complex decreases by 50% at a pH of 7.20 and by 90% at a pH of 6.80.
- Trauma-Induced Coagulopathy (TIC): Driven by tissue trauma, shock, consumption of factors, hyperfibrinolysis, and endothelial glycocalyx degradation.
Modern critical care medicine expands this concept to the Lethal Diamond, recognizing Hypocalcemia as the critical fourth pillar.
Ionized calcium ($\text{iCa}^{2+}$) is Factor IV in the coagulation cascade and is essential for platelet activation, fibrin assembly, and vascular tone. Transfusion of citrate-preserved blood products (PRBCs and FFP) rapidly chelates serum ionized calcium. An $\text{iCa}^{2+} < 0.9 \text{ mmol/L}$ severely impairs cardiac contractility and exacerbates refractory coagulopathic bleeding.
Principles of Damage Control Resuscitation (DCR)
Damage Control Resuscitation prioritizes rapid hemostasis and metabolic stability over normotensive volume restoration prior to definitive surgical intervention.
1. Permissive Hypotension (Hemostatic Resuscitation)
- Target Parameters: Maintain Systolic Blood Pressure (SBP) at $80 - 90 \text{ mmHg}$ and Mean Arterial Pressure (MAP) at $\approx 50 - 60 \text{ mmHg}$ in patients with active non-compressible torso hemorrhage.
- Rationale: Lower hydrostatic pressure prevents "popping the clot" (dislodging fragile initial hemostatic plugs) and limits dilutional displacement of endogenous clotting factors.
- CRITICAL EXCEPTION — Traumatic Brain Injury (TBI): In patients with confirmed or suspected TBI (isolated or concomitant), permissive hypotension is strictly contraindicated. Hypotension ($\text{SBP} < 90 \text{ mmHg}$) doubles mortality in TBI by compromising Cerebral Perfusion Pressure ($\text{CPP} = \text{MAP} - \text{ICP}$). Target $\text{SBP} \ge 110 \text{ mmHg}$ (or $\text{MAP} \ge 80 \text{ mmHg}$) in patients aged 15–49 or 65+, and $\text{SBP} \ge 100 \text{ mmHg}$ in patients aged 50–64.
2. Elimination of Crystalloid Overload
- Large-volume isotonic crystalloids (0.9% Normal Saline or Lactated Ringer's) cause dilutional coagulopathy, hyperchloremic metabolic acidosis (with 0.9% NaCl), tissue edema, and increased mortality. Crystalloid administration should be restricted to minimal boluses only when blood products are unavailable.
Massive Transfusion Protocols (MTP) & Ratios
Massive Transfusion is defined as the administration of $\ge 10 \text{ units}$ of Packed Red Blood Cells (PRBCs) within 24 hours, $\ge 4 \text{ units}$ within 1 hour, or the replacement of $> 50%$ of total blood volume in 3 hours.
Balanced Product Ratios (1:1:1)
Modern MTP mandates a 1:1:1 ratio of blood components:
This ratio reconstructs reconstituted whole blood (yielding a hematocrit of $\sim 29%$, platelet count of $\sim 88,000/\mu\text{L}$, and coagulation factor activity of $\sim 65%$). Low-Titer O Positive/Negative Whole Blood (LTOWB) is increasingly utilized in critical care transport as it delivers unseparated, fully functional red cells, plasma factors, and platelets in a single physiological unit.
Pharmacological Resuscitation & Calcium Protocol
- Tranexamic Acid (TXA): A synthetic lysine analog that competitively inhibits plasminogen activation, blocking fibrinolysis.
- Dosing: Administer $1 \text{ g}$ IV/IO bolus over 10 minutes within 3 hours of injury (CRASH-2 trial demonstrated significant reduction in mortality when given $< 3 \text{ hours}$; administration $> 3 \text{ hours}$ post-injury increases mortality). Follow with a second $1 \text{ g}$ IV maintenance infusion over 8 hours.
- CRASH-3 Trial: Supports TXA utility in mild-to-moderate traumatic brain injury (GCS 9–14) without increasing thromboembolic risk.
- Calcium Administration: Administer $1 \text{ g}$ Calcium Chloride (or $3 \text{ g}$ Calcium Gluconate) IV/IO for every 4 units of blood products transfused, titrating to maintain ionized calcium $\text{iCa}^{2+} > 1.1 \text{ mmol/L}$. Note: Calcium chloride delivers 3x more elemental calcium per gram than calcium gluconate and requires central or secure large-bore IV access.
Thromboelastography (TEG) & ROTEM Interpretation
Viscoelastic assays evaluate the viscoelastic properties of whole blood from initial fibrin formation through clot maturation and lysis, providing real-time point-of-care guidance for targeted transfusions.
TEG Tracing Diagram:
Split Point (SP)
|---| Reaction Time (R-time)
|------| K-time
|======\ Alpha Angle (α)
|=======\================ MAX AMPLITUDE (MA)
|========\ |
|=========\--------------| LY30 (% Lysis at 30 min)
| TEG Parameter | Normal Range | Clinical Significance & Defect | Specific Treatment Target |
|---|---|---|---|
| R-time (Reaction Time) | $5 - 10 \text{ min}$ | Time to initial fibrin clot formation; measures clotting factor levels | Fresh Frozen Plasma (FFP) ($10 - 15 \text{ mL/kg}$) or PCC |
| K-time | $1 - 3 \text{ min}$ | Time from R-time until clot reaches 20 mm amplitude; measures clot kinetics & fibrinogen | Cryoprecipitate ($10 \text{ units}$) or Fibrinogen Concentrate |
| Alpha Angle ($\alpha$) | $53^\circ - 72^\circ$ | Slope of tracing curve; reflects fibrinogen interaction with platelets | Cryoprecipitate ($1 \text{ unit per 10 kg}$) |
| Max Amplitude (MA) | $50 - 70 \text{ mm}$ | Peak dynamic strength of clot; 80% platelet count/function, 20% fibrinogen | Platelets ($1 \text{ apheresis unit}$) $\pm$ DDAVP ($0.3 \ \mu\text{g/kg}$) |
| LY30 | $0% - 3%$ | Percentage of clot retraction/lysis 30 minutes after MA; measures fibrinolysis | Tranexamic Acid (TXA) ($1 \text{ g}$ IV bolus) |
| ROTEM Equivalent | CT (Clotting Time) | CFT (Clot Formation Time) / α-angle | MCF (Max Clot Firmness) / ML (Max Lysis) |
A 32-year-old male polytrauma patient with an isolated severe closed head injury (GCS 6) has an initial blood pressure of 84/48 mmHg (MAP 60 mmHg) and active femoral hemorrhage. What is the most appropriate blood pressure target during critical care transport?
During a massive transfusion protocol for a severe pelvic fracture patient who has received 8 units of PRBCs and 8 units of FFP, point-of-care TEG reveals an R-time of 6.2 minutes (normal 5–10 min), an Alpha angle of 62° (normal 53–72°), and a Maximum Amplitude (MA) of 38 mm (normal 50–70 mm). What is the priority intervention?
A transport team is managing a 24-year-old gunshot wound victim 90 minutes post-injury. Which statement correctly describes the administration of Tranexamic Acid (TXA) and Calcium in this setting?